Stock Analysis
Revvity, Inc. (RVTY) Stock Analysis
Revvity, Inc. (RVTY) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Revvity, Inc. (RVTY) currently has an AIQ Score of 57/100, indicating a neutral setup. Momentum is the strongest factor at 81/100. Value is the weakest current factor at 42/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
RVTY at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $130.22 |
| AIQ Score | 57/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $14.12B |
| P/E Ratio | 23.66 |
| Forward P/E | — |
| EPS | $0.47 |
| Revenue TTM | $729.69M |
| Dividend Yield | 0.00% |
| Beta | 1.07 |
| Volume | 1.18M |
| 52-week range | $81.22-$133.00 |
| RSI 14 | 73.36 |
| 50-Day SMA | $116.40 |
| 200-Day SMA | $102.36 |
| Analyst Price Target | $112.83 |
| Next Earnings | Oct 26, 2026 |
RVTY
OverviewRVTY Stock Analysis Summary
Revvity, Inc. (RVTY) currently has an AIQ Score of 57/100, indicating a neutral setup. Momentum is the strongest factor at 81/100. Value is the weakest current factor at 42/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, RVTY has AIQ Score of 57/100 with Momentum base of 81/100 and fading Value at 42/100. Wait for component alignment before adding exposure.
Momentum (81/100) leads while Value (42/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -0.31% stock move · RVTY classified in Medical - Diagnostics & Research.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is RVTY Bullish or Bearish Right Now?
RVTY currently has a neutral overall setup. Momentum is the strongest factor at 81/100, while Value is weakest at 42/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 81/100.
- - Risk Resilience is supportive at 64/100.
- - Price is +11.88% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (37 vs 6).
- - Value is the current constraint at 42/100.
- - Analyst target implies -13.35% downside from the latest quote.
Current Consensus
RVTY's Technical Analysis Consensus is currently Strong Buy, with 37 buy, 2 neutral, and 6 sell votes. RVTY's 14-day RSI is 73.36, which places the stock in an overbought momentum range. RVTY's beta is 1.07, indicating market sensitivity broadly in line with the market.
What Changed in RVTY?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the RVTY Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
RVTY Decision Framework
Public evidence layers, setup checks, and risk context for Revvity, Inc..
Revvity, Inc. (RVTY) Stock Analysis
Revvity, Inc. has an AIQ Score of 57/100 in a Neutral regime. Momentum is strongest at 81/100. Beta is 1.07, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | RVTY is in a Neutral AIQ regime with score 57/100. |
| Signal Conflict | The primary conflict is that momentum leads at 81/100 while value lags at 42/100. |
| Factor Evidence | Momentum 81/100 · Value 42/100 · Quality 50/100 · Risk 64/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 81/100.
Momentum is 81/100 and RSI (14) is 73.4.
RVTY is in a Neutral regime at 57/100.
Risk factor is 64/100 with beta 1.07 and annual volatility 37.79%.
Current conflict: momentum leads at 81/100 while value lags at 42/100.
RVTY Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
RVTY Fundamentals
RVTY valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
RVTY Technical Analysis
RVTY technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
RVTY Stock Catalysts
Track RVTY earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
RVTY Dividend Analysis
RVTY dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
RVTY Financial Data
RVTY revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
RVTY Risk Analysis
RVTY volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
RVTY Stock News
RVTY stock news, market tone, recent headlines, and catalyst context.
RVTY vs Life Sciences / Tools / CRO Peers
Current peer cohort: RVTY · TECH · TMO · TXG · ZTS. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| RVTY Current stock | 57/100 | 42/100 | 81/100 | 64/100 | 1.2 | 37.79% | Current |
| TECH Bio-Techne | 56/100 | 26/100 | 62/100 | 89/100 | 0.82 | 46.71% | RVTY vs TECH |
| TMO Thermo Fisher Scientific | 51/100 | 39/100 | 60/100 | 62/100 | 0.77 | 30.64% | RVTY vs TMO |
| TXG 10x Genomics | 50/100 | 34/100 | 67/100 | 38/100 | 2.42 | 72.52% | RVTY vs TXG |
| ZTS Zoetis | 64/100 | 62/100 | 63/100 | 55/100 | -1.78 | 37.61% | RVTY vs ZTS |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 4, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 5, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jul 5, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching RVTY
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for RVTY
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
RVTY Stock FAQ
What is RVTY stock price today?
Revvity, Inc.'s current stock price is $130.22. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is RVTY bullish or bearish right now?
RVTY's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is RVTY's market cap?
RVTY's market cap is $14.12B based on the latest completed market-close snapshot from Sep 4, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is RVTY's current P/E ratio?
RVTY's current P/E ratio is 23.66 based on the latest completed market-close snapshot from Sep 4, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is RVTY's RSI?
RVTY's 14-day RSI is 73.36 based on the latest completed market-close snapshot from Sep 4, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is RVTY above its 50-day and 200-day moving averages?
RVTY is 11.88% from its 50-day SMA and 27.21% from its 200-day SMA based on the latest completed market-close snapshot from Sep 4, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is RVTY's next earnings date?
RVTY's next earnings date is currently listed as Oct 26, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does RVTY pay a dividend?
RVTY's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 4, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.